Spyre Therapeutics Inc. annual earnings per share (EPS) for fiscal TTM was $-0.52, an increase of 84.2% from $-3.30 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-0.52 | $-3.30 | $-4.42 | $-49.12 | $-24.86 | $-25.02 | $-37.89 | $-61.23 | $-53.25 | $-27.00 | $-55.40 | $-24.71 | $-10.00 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | — | $-0.20 | $-1.05 | $-0.19 | $-0.60 | $-0.74 | $-1.20 | $-1.36 | $-0.86 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More SYRE metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All SYRE financial statements → Interactive SYRE charts →
About TickerBase · Data methodology & sources · Privacy · Terms